Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Preoxygenation for Difficult Airway Management

NCT: NCT03604120 · COMPLETED

NCT IDNCT03604120
StatusCOMPLETED
Start Date2018-09-19
Completion2021-03-08
SponsorNantes University Hospital (OTHER)
First posted
Last updated

Brief Summary

Tracheal intubation in operating room for patients at risk of difficult intubation remains a critical event. The aim of this study is to determine whether Nasal High Flow Therapy by nasal cannula Optiflow® administered before and during intubation is more efficient than the standard care for pre-oxygenation and oxygenation during anticipated difficult intubation

Frequently Asked Questions

What is Preoxygenation for Difficult Airway Management?

Preoxygenation for Difficult Airway Management is a clinical trial registered under NCT03604120. Current status: COMPLETED.

What is the status of NCT03604120?

The current status of NCT03604120 (Preoxygenation for Difficult Airway Management) is: COMPLETED.

When did Preoxygenation for Difficult Airway Management start?

Preoxygenation for Difficult Airway Management started on 2018-09-19.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.